# Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.

> **NCT00210106** · NA · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 52 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** Ablathermy

## Key facts

- **NCT ID:** NCT00210106
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2008-12
- **Final completion:** 2010-05
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210106, "Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00210106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*